Search research articles
Contact Us
Filters
Showing results (31-40 of 96) with videos related to
Page
of 10
Sort By:
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
February 1, 2017
Association between Aβ and tau accumulations and their influence on clinical features in aging and Alzheimer's disease spectrum brains: A [<sup>11</sup>C]PBB3-PET study
Hitoshi Shimada, Soichiro Kitamura, Hitoshi Shinotoh, et al.
EJNMMI Research
|
March 13, 2016
A new method to quantify tau pathologies with (11)C-PBB3 PET using reference tissue voxels extracted from brain cortical gray matter
Yasuyuki Kimura, Hironobu Endo, Masanori Ichise, et al.
Journal of Alzheimer'S Disease : JAD
|
July 30, 2019
Classification of Clinically Diagnosed Alzheimer's Disease Associated with Diabetes Based on Amyloid and Tau PET Results
Naoto Takenoshita, Soichiro Shimizu, Hidekazu Kanetaka, et al.
Brain : a Journal of Neurology
|
June 19, 2010
Cholinergic imaging in corticobasal syndrome, progressive supranuclear palsy and frontotemporal dementia
Shigeki Hirano, Hitoshi Shinotoh, Hitoshi Shimada, et al.
Masui. the Japanese Journal of Anesthesiology
|
September 23, 2010
[Landiolol infusion attenuates increase in heart rate, but does not prevent increase in blood pressure in response to emergence from anesthesia and tracheal extubation]
Tatsuo Horiuchi, Shinya Uchida, Yuji Kadoi, et al.
Clinical Neuropharmacology
|
November 26, 2009
Estimation of plasma IC50 of donepezil for cerebral acetylcholinesterase inhibition in patients with Alzheimer disease using positron emission tomography
Tsuneyoshi Ota, Hitoshi Shinotoh, Kiyoshi Fukushi, et al.
Neuroimage
|
June 29, 2017
Normative data of dopaminergic neurotransmission functions in substantia nigra measured with MRI and PET: Neuromelanin, dopamine synthesis, dopamine transporters, and dopamine D<sub>2</sub> receptors
Hiroshi Ito, Hiroshi Kawaguchi, Fumitoshi Kodaka, et al.
Current Alzheimer Research
|
March 4, 2015
Amyloid β accumulation assessed with ¹¹C-Pittsburgh compound B PET and postmortem neuropathology
Hiroyuki Hatsuta, Masaki Takao, Kenji Ishii, et al.
Frontiers in Neurology
|
March 20, 2023
Case report: Saccadic ping-pong gaze in progressive supranuclear palsy with predominant postural instability
Hikari Nunomura, Taketoshi Kasahara, Taku Hatano, et al.
Clinical Drug Investigation
|
September 21, 2021
Pharmacokinetics, Pharmacodynamics, and Tolerability of AZD5718, an Oral 5-Lipoxygenase-Activating Protein (FLAP) Inhibitor, in Healthy Japanese Male Subjects
Jane Knöchel, Karin Nelander, Maria Heijer, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 96) with videos related to
Sort By:
Page
of 10
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
February 1, 2017
Association between Aβ and tau accumulations and their influence on clinical features in aging and Alzheimer's disease spectrum brains: A [<sup>11</sup>C]PBB3-PET study
Hitoshi Shimada, Soichiro Kitamura, Hitoshi Shinotoh, et al.
EJNMMI Research
|
March 13, 2016
A new method to quantify tau pathologies with (11)C-PBB3 PET using reference tissue voxels extracted from brain cortical gray matter
Yasuyuki Kimura, Hironobu Endo, Masanori Ichise, et al.
Journal of Alzheimer'S Disease : JAD
|
July 30, 2019
Classification of Clinically Diagnosed Alzheimer's Disease Associated with Diabetes Based on Amyloid and Tau PET Results
Naoto Takenoshita, Soichiro Shimizu, Hidekazu Kanetaka, et al.
Brain : a Journal of Neurology
|
June 19, 2010
Cholinergic imaging in corticobasal syndrome, progressive supranuclear palsy and frontotemporal dementia
Shigeki Hirano, Hitoshi Shinotoh, Hitoshi Shimada, et al.
Masui. the Japanese Journal of Anesthesiology
|
September 23, 2010
[Landiolol infusion attenuates increase in heart rate, but does not prevent increase in blood pressure in response to emergence from anesthesia and tracheal extubation]
Tatsuo Horiuchi, Shinya Uchida, Yuji Kadoi, et al.
Clinical Neuropharmacology
|
November 26, 2009
Estimation of plasma IC50 of donepezil for cerebral acetylcholinesterase inhibition in patients with Alzheimer disease using positron emission tomography
Tsuneyoshi Ota, Hitoshi Shinotoh, Kiyoshi Fukushi, et al.
Neuroimage
|
June 29, 2017
Normative data of dopaminergic neurotransmission functions in substantia nigra measured with MRI and PET: Neuromelanin, dopamine synthesis, dopamine transporters, and dopamine D<sub>2</sub> receptors
Hiroshi Ito, Hiroshi Kawaguchi, Fumitoshi Kodaka, et al.
Current Alzheimer Research
|
March 4, 2015
Amyloid β accumulation assessed with ¹¹C-Pittsburgh compound B PET and postmortem neuropathology
Hiroyuki Hatsuta, Masaki Takao, Kenji Ishii, et al.
Frontiers in Neurology
|
March 20, 2023
Case report: Saccadic ping-pong gaze in progressive supranuclear palsy with predominant postural instability
Hikari Nunomura, Taketoshi Kasahara, Taku Hatano, et al.
Clinical Drug Investigation
|
September 21, 2021
Pharmacokinetics, Pharmacodynamics, and Tolerability of AZD5718, an Oral 5-Lipoxygenase-Activating Protein (FLAP) Inhibitor, in Healthy Japanese Male Subjects
Jane Knöchel, Karin Nelander, Maria Heijer, et al.
Page
of 10